Use of L-Arginine for Inhaled Nitric Oxide (iNO) Dependent Hepatopulmonary Syndrome (HPS) Post-Liver Transplant
نویسندگان
چکیده
منابع مشابه
Inhaled Nitric Oxide (iNO) Therapy
Kaiser Permanente Clinical Review Criteria are developed to assist in administering plan benefits. These criteria neither offer medical advice nor guarantee coverage. Kaiser Permanente reserves the exclusive right to modify, revoke, suspend or change any or all of these Review Criteria, at Kaiser Permanente's sole discretion, at any time, with or without notice. Member contracts differ in their...
متن کاملInhaled Nitric Oxide (iNO) Therapy
NOTICE: Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc., provide these Clinical Review Criteria for internal use by their members and health care providers. The Clinical Review Criteria only apply to Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc. Use of the Clinical Review Criter...
متن کاملUse of inhaled epoprostenol to improve arterial oxygenation post liver transplant in a ventilated patient with hepatopulmonary syndrome
Hepatopulmonary syndrome (HPS) occurs in approximately 4 to 29% of patients with liver disease [1]. Intrapulmonary vascular dilatation results in shunting and arterial hypoxemia. Although multiple treatments have been attempted with variable success, this is the first report of the acute use of inhaled epoprostenol to improve oxygenation in a ventilated patient with HPS who remained profoundly ...
متن کاملThe Successful Use of Inhaled Nitric Oxide in the Management of Severe Hepatopulmonary Syndrome after Orthotopic Liver Transplantation
Hepatopulmonary syndrome (HPS) is characterized by pulmonary vasodilation and subsequent hypoxemia in the setting of hepatic dysfunction. There is currently no pharmacologic intervention that has been shown to significantly affect outcomes and liver transplantation remains the mainstay of therapy. Unfortunately, patients undergoing liver transplantation are at high risk of significant hypoxemia...
متن کاملScreening of hepatopulmonary syndrome (HPS) with CEUS and pulse-oximetry in liver cirrhosis patients eligible for liver transplant.
BACKGROUND AND AIM The prevalence of hepatopulmonary syndrome (HPS) in the setting of cirrhosis ranges between 4%-47%. We aimed to detect a correlation between heart and lungs findings on contrast-enhanced ultrasound (CEUS)and pulse-oximetry, in order to early detect HPS and thus to improve patients referral to orthotopic liver transplantation(OLT). METHODS We considered at risk for HPS all p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Evolution of Medical and Dental Sciences
سال: 2020
ISSN: 2278-4748,2278-4802
DOI: 10.14260/jemds/2020/242